PATENT CLAIM ANALYSIS

Application Number: 15941443
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "054000"]

Abstract:
An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying property in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.

Claim (Index 20):
The method according to claim  1 , wherein the glycosaminoglycan into which the hydrophobic group is introduced via the spacer chain blocks transmission of the ultraviolet ray at a wavelength of 200 to 300 nm by 70 to 100%, when the glycosaminoglycan into which the hydrophobic group is introduced via the spacer chain is made into an aqueous solution of 0.1% by weight.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.33846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13070210', '14903817', '15563196', '10548533', '11662087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7080050362946261
- 35 USC 102 Novelty (BERT): 0.5431074037591973
- Combined Prediction Score: 0.6915152730410833
- Mean Citation Score: 181.319152
- Max Citation Score: 360.2165
- Similarity Product: 231.0080734145045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test